{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Health Affairs This Week","title":"CMS Drug Price Negotiation Guidance Updates with Rachel Sachs","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/f1481bfd\"></iframe>","width":"100%","height":180,"duration":992,"description":"Health Affairs' Jeff Byers welcomes Rachel Sachs from Washington University in St. Louis and Deputy Editor Chris Fleming back to the pod to discuss CMS' final guidance for the latest round of the Medicare drug price negotiation program.\nRelated Articles:\nAdministration Releases Medicare Drug Price Negotiation Program Final Guidance For 2028 (Health Affairs Forefront)\nThe Role of Combination Drugs in the Medicare Drug Price Negotiation Program (JAMA)\nArticulating policy options regarding implementation of the Medicare drug price negotiation program’s renegotiation provision (Brookings Institution)\nEye on The IRA (Health Affairs)","thumbnail_url":"https://img.transistorcdn.com/1yTEmrg3NcfwPvygDcOosqdCKJnotdzHk5P0Oq8y-us/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzE2NjA3LzE2MDY4/MzkyNjUtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}